A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer

被引：0
|
作者：
Kim, H.
Lee, G.
Kim, H.
Lee, O.
Hwang, I.
Kang, J.
机构：
[1] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea
[2] Kangwon Natl Univ, Sch Med, Chunchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15583
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
    Park, Sook Ryun
    Kim, Mi-Jung
    Nam, Byung-Ho
    Kim, Chan Gyoo
    Lee, Jong Yeul
    Cho, Soo-Jeong
    Kong, Sun-Young
    Park, Young-Iee
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 32 - 42
  • [42] A PHASE II STUDY OF S-1 COMBINED WITH IRINOTECAN AND OXALIPLATIN IN PATIENTS WITH METASTATIC GASTRIC CARCINOMA
    Park, S. R.
    Park, Y.
    Park, Y. L.
    Kim, N. K.
    ANNALS OF ONCOLOGY, 2008, 19 : 173 - 173
  • [43] Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study
    Wang, Mei
    Wu, Meihong
    Wang, Wei
    Wang, Qingshui
    Wang, Yajie
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (1-2) : 24 - 28
  • [44] Three-Weekly S-1 Monotherapy as First-Line Treatment in Elderly Patients with Recurrent or Metastatic Gastric Cancer
    Lim, Joo Han
    Lee, Moon Hee
    Kim, Hyung Gil
    Shin, Yong Woon
    Yi, Hyeon Gyu
    Shin, Seok Hwan
    Hur, Yoon Seok
    Kim, Chul Soo
    Chang, Hye Jeong
    GUT AND LIVER, 2010, 4 (04) : 503 - 507
  • [45] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [46] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    X. Wang
    M. L. Wang
    L. Y. Zhou
    X. Y. Lu
    J. F. Yang
    H. G. Yu
    Clinical and Translational Oncology, 2013, 15 : 836 - 842
  • [47] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy in patients with advanced or relapsed gastric cancer
    Lee, J. J.
    Kim, S. Y.
    Chung, H. C.
    Lee, K. H.
    Song, H. S.
    Woo, I. S.
    Hong, Y. S.
    Kang, W. K.
    Choi, J. H.
    Choi, I. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] RANDOMIZED PHASE II STUDY OF OXALIPLATIN AND S-1 (OS) VERSUS OXALIPLATIN AND CAPECITABINE (XELOX) IN PATIENTS WITH METASTATIC OR RECURRENT COLORECTAL CANCER
    Zang, D. Y.
    Chung, I. J.
    Oh, H.
    Park, K. U.
    Lee, K. H.
    Han, B.
    Choi, D. R.
    Kim, H. S.
    Kim, J. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 193 - 193
  • [49] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    Wang, X.
    Wang, M. L.
    Zhou, L. Y.
    Lu, X. Y.
    Yang, J. F.
    Yu, H. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (10): : 836 - 842
  • [50] Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
    Liu, Chaoying
    Sun, Qing
    Hang, Xiaosheng
    Zhong, Baoliang
    Wang, Daoyuan
    ANTI-CANCER DRUGS, 2008, 19 (08) : 825 - 831
12345